UK Biopharmaceutical Sector Strength & Opportunity 2015

Companies, Employment and Turnover

- 1,948 Companies
- £40bn revenues
- 107,000 employees
- 48% of employment and 35% of companies in the UK life science industry

Distribution of Employment Across UK

- 75% of employment in sector excluding services and supply chain
- 213 Locations = 80% Total Sector Employment
- 80 Locations = 80% Sector employment that excludes service and supply chain

Largest Segments by Revenue

1. Small Molecules
2. Therapeutic Proteins
3. Vaccines

- 75% of the sector that excludes the service and supply chain employed by Global Top 25
- Companies who obtain the majority of their revenue from medicines based on small molecules employ the largest percentage. 67% of employment in the small molecule segment is in the Global Top 25 pharmaceutical companies.

Growth Trends

Over 2011 to 2015 the sector trend data shows a small decrease in estimated employment, while revenue decreased by -1.3% CAGR. The majority of the employment and revenue reduction was in the small molecule segment dominated by the larger biopharmaceutical companies.

Over the same period the service and supply chain employment grew at a CAGR of 3.7%.

Service and Supply Chain

- An essential cluster of specialist suppliers supports the medical biotechnology and pharmaceutical sectors in the UK. Does not include non-life science companies.
- 1,285 companies. Employing 45,123 staff. Generating £11bn in revenues
- 72% of total supply chain employment
- Employment in the service & supply chain grew by 3.7% CAGR over 2011-2015 and 4.8% CAGR in revenue

Advanced Therapy Medicinal Products employment has grown by 6% over 2011-2015 the highest of the therapy segments.

Clinical Research organisations employment has grown by 13% over 2015-2015 the highest for the whole sector.

For More Info: www.lifesciences.ukti.gov.uk

www.gov.uk/government/collections/bioscience-and-health-technology-database-annual-reports

- CAGR = Compound Annual Growth Rate